Evidence map›Paper›PMID 29468115›Full record

ArticleMetabolic engineering communications2016

An optimized method for accurate quantification of cell migration using human small intestine cells.

Steffen Nyegaard, Brian Christensen, Jan Trige Rasmussen

Open access · goldAbstract read
In one paragraph

Article in Metabolic engineering communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Enhanced Production of Bryonolic Acid inPlants (Basel, Switzerland) · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Steffen NyegaardDepartment of Molecular Biology and Genetics - Molecular Nutrition, Aarhus University, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.
Brian ChristensenDepartment of Molecular Biology and Genetics - Molecular Nutrition, Aarhus University, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.
Jan Trige RasmussenDepartment of Molecular Biology and Genetics - Molecular Nutrition, Aarhus University, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.
Aarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantifying the ability of a compound to modulate cell migration rate is a crucial part of many studies including those on chemotaxis, wound healing and cancer metastasis. Existing migration assays all have their strengths and weaknesses. The "scratch" assay is the most widely used because it seems appealingly simple and inexpensive. However, the scratch assay has some important limitations, as the tool introducing the "wound" might injure/stress the boundary cells and/or harm underlying matrix coatings, which in both cases will affect cell migration. This described method is a Cell Exclusion Zone Assay, in which cell-free areas are created by growing cells around removable silicone stoppers. Upon appropriate staining with fluorescent dyes and microscopically visualizing the monolayers, the migration rate is then quantified by counting the cells (nuclei) intruding the void area left by the silicone insert. In the current study human small intestine epithelial cells were seeded on a physiological substrate matrix to produce collectively migrating monolayers. Different substrates were tested to determine the optimal surface for enterocyte adherence and migration and morphological changes monitored. Recombinant human epidermal growth factor and osteopontin purified from urine were tested to see if the established migration assay produces accurate and reliable migration data with human small intestine cells. The obtained data accurately confirmed that the two bioactive proteins modulate cellular migration in a dose-dependent manner. The presented assay can likely be converted for use with other adherent cell lines or substrate matrices and allows for high throughput, while cost is kept low and versatility high. Co-staining can be applied in order to assay for cell death, different cell types, cell stress and others allowing intricate analysis of migration rate of mixed populations and correction for cell viability.

Indexed as

Bioactive(BME), Basal membrane extract(Caco-2), human epithelial colorectal adenocarcinoma cellsCollective migration(DMEM), Dulbecco's modified Eagle medium(ECM), Extracellular matrix(EGF), Recombinant human epidermal growth factorEpithelium(FBS), fetal bovine serum(FHs-74 int), non-malignant human fetal small intestine cells(FRET), Förster resonance energy transferMigration assay(OPN), osteopontin(ROI), region of interestSmall intestine cellsWound healing

Identifiers

PMID29468115
PMCPMC5779728
OpenAlexW2301917917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.